These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3691149)

  • 21. [The development of continuous crystallizer and observation of formation and growth of calcium oxalate crystals].
    Suzuki K; Domiki C; Tsugawa R
    Hinyokika Kiyo; 1991 Jun; 37(6):569-75. PubMed ID: 1716408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary inhibitor of the formation of calcium oxalate.
    Sutor DJ; Percival JM; Doonan S
    Br J Urol; 1979 Aug; 51(4):253-5. PubMed ID: 223711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro.
    Nicar MJ; Hill K; Pak CY
    J Bone Miner Res; 1987 Jun; 2(3):215-20. PubMed ID: 3455168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.
    Chung J; Granja I; Taylor MG; Mpourmpakis G; Asplin JR; Rimer JD
    Nature; 2016 Aug; 536(7617):446-50. PubMed ID: 27501150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium oxalate dihydrate formation in urine.
    Martin X; Smith LH; Werness PG
    Kidney Int; 1984 Jun; 25(6):948-52. PubMed ID: 6471675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis.
    Grases F; Genestar C; Conte A; March P; Costa-Bauzá A
    Br J Urol; 1989 Sep; 64(3):235-7. PubMed ID: 2553195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scanning electron microscopic study of the effect of citrate and pyrophosphate on calcium oxalate crystal morphology.
    Shirane Y; Kagawa S
    J Urol; 1993 Dec; 150(6):1980-3. PubMed ID: 8230549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.
    Tiselius HG
    Clin Chim Acta; 1982 Jul; 122(3):409-18. PubMed ID: 7105424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of factors affecting calcium oxalate crystalline aggregation.
    Grases F; Costa-Bauzá A
    Br J Urol; 1990 Sep; 66(3):240-4. PubMed ID: 1698500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of magnesium on calcium oxalate urolithiasis.
    Su CJ; Shevock PN; Khan SR; Hackett RL
    J Urol; 1991 May; 145(5):1092-5. PubMed ID: 2016799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alkalinizing treatment as a preventative of recurrent calcium oxalate lithiasis].
    Cifuentes Delatte L
    Arch Esp Urol; 1991 Oct; 44(8):903-10. PubMed ID: 1796852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibitory activity of urinary macromolecule upon calcium oxalate crystal aggregation using an aggregometer].
    Ebisuno S; Miyata K; Kohjimoto Y; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1993 Feb; 84(2):339-44. PubMed ID: 8464186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of sodium citrate, potassium citrate, and citric acid in preventing experimental calcium oxalate urolithiasis in rats.
    Ogawa Y; Tanaka T; Yamaguchi K; Morozumi M; Kitagawa R
    Hinyokika Kiyo; 1987 Nov; 33(11):1772-7. PubMed ID: 3445859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.
    Ryall RL; Harnett RM; Marshall VR
    Clin Chim Acta; 1981 May; 112(3):349-56. PubMed ID: 6263523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis.
    Fetner CD; Barilla DE; Townsend J; Pak CY
    J Urol; 1978 Oct; 120(4):399-401. PubMed ID: 702659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tamm-Horsfall mucoproteins promote calcium oxalate crystal formation in urine: quantitative studies.
    Rose GA; Sulaiman S
    J Urol; 1982 Jan; 127(1):177-9. PubMed ID: 7057493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gel model for measuring crystallization inhibitor activity].
    Bothor C; Berg W; Börner RH; Jakob M
    Z Urol Nephrol; 1982 Oct; 75(10):689-98. PubMed ID: 6297185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different estimates of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Eur Urol; 1983; 9(4):231-4. PubMed ID: 6873126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urine saturation with calcium oxalate in urolithiasis].
    Bogado CE; Zanchetta JR
    Medicina (B Aires); 1988; 48(1):39-44. PubMed ID: 3216787
    [No Abstract]   [Full Text] [Related]  

  • 40. Urinary excretion of calcium, magnesium, oxalate and citrate in duodenal ulcer patients. Preliminary results before and up to five years after highly selective vagotomy.
    Schwille PO; Scholz D; Hanisch E; Zeuner E; Schwendtner H; Husemann B; Mühe E; Sigel A
    Klin Wochenschr; 1983 Sep; 61(17):845-50. PubMed ID: 6632726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.